| Literature DB >> 24453878 |
Koji Otani1, Shinichi Kikuchi1, Shoji Yabuki1, Tamaki Igarashi1, Takuya Nikaido1, Kazuyuki Watanabe1, Shinichi Konno1.
Abstract
Lumbar spinal stenosis (LSS) is common in the elderly. However, there have been few reports on its impact on quality of life (QoL) in community-dwelling individuals. The purpose of this study was to clarify how symptomatic LSS affects QoL at the community level. A total of 1862 people (697 males and 1165 females, most subjects were between 40 and 85 y.o.) agreed to participate and were interviewed. The presence of symptomatic LSS was assessed by a specially designed questionnaire. The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) was also administered. In addition, the presence of comorbid conditions that affect QoL, such as osteoarthritis of the knee and hip, cardiovascular disease, cerebrovascular disease, or respiratory disease, was also analyzed. The prevalence of symptomatic LSS gradually increased with age. Furthermore, the presence of symptomatic LSS had a strong negative effect on all 8 physical and mental domains and the physical component summary (PCS) (OR: 1.547-2.544) but not the mental component summary (MCS). In comparison with comorbid conditions, LSS had a much stronger negative impact on health-related QoL (HR-QoL). The current study confirmed that the presence of symptomatic LSS might have a strong negative influence on HR-QoL in the community setting.Entities:
Mesh:
Year: 2013 PMID: 24453878 PMCID: PMC3885225 DOI: 10.1155/2013/590652
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Age-specific participation rate of the local population (total, male/female).
| Age | Population | Participant |
| ||||
|---|---|---|---|---|---|---|---|
| Male | Female | M + F ( | Male | Female | M + F ( | ||
| 15–19 | 213 | 207 | 420 | 0 | 2 | 2 | 0.5 |
| 20–24 | 176 | 135 | 311 | 8 | 8 | 16 | 5.1 |
| 25–29 | 179 | 157 | 336 | 11 | 8 | 19 | 5.7 |
| 30–34 | 207 | 181 | 388 | 22 | 16 | 38 | 9.8 |
| 35–39 | 227 | 185 | 412 | 23 | 19 | 42 | 10.2 |
| 40–44 | 263 | 213 | 476 | 22 | 34 | 56 | 11.8 |
| 45–49 | 290 | 278 | 568 | 36 | 41 | 77 | 13.6 |
| 50–54 | 349 | 322 | 671 | 42 | 78 | 120 | 17.9 |
| 55–59 | 444 | 320 | 764 | 49 | 84 | 133 | 17.4 |
| 60–64 | 341 | 360 | 701 | 78 | 144 | 222 | 31.7 |
| 65–69 | 385 | 448 | 833 | 104 | 205 | 309 | 37.1 |
| 70–74 | 442 | 507 | 949 | 117 | 235 | 352 | 37.1 |
| 75–79 | 342 | 438 | 780 | 114 | 183 | 297 | 38.1 |
| 80–84 | 191 | 366 | 557 | 51 | 85 | 136 | 24.4 |
| 85–89 | 101 | 222 | 323 | 16 | 17 | 33 | 10.2 |
| 90–94 | 48 | 123 | 171 | 3 | 2 | 5 | 2.9 |
|
| |||||||
| 4198 | 4462 | 8660 | 696 | 1166 | 1862 | 21.5 | |
Age-specific prevalence of lumbar spinal stenosis (LSS) (total, male/female).
| Age | Prevalence of LSS (%) |
| |
|---|---|---|---|
| Male | Female | ||
| 15–19 | — | 0 | — |
| 20–24 | 0 | 0 | 1.0 |
| 25–29 | 9.1 | 0 | 0.579 |
| 30–34 | 4.5 | 6.3 | 0.671 |
| 35–39 | 0 | 5.3 | 0.452 |
| 40–44 | 4.5 | 5.9 | 0.661 |
| 45–49 | 8.3 | 7.3 | 0.598 |
| 50–54 | 4.8 | 14.1 | 0.100 |
| 55–59 | 16 | 14.3 | 0.486 |
| 60–64 | 16.7 | 16.6 | 0.561 |
| 65–69 | 19.8 | 20.4 | 0.516 |
| 70–74 | 20.5 | 28.5 | 0.006 |
| 75–79 | 22.4 | 33.5 | 0.026 |
| 80–84 | 28 | 44.2 | 0.045 |
| 85–89 | 18.8 | 47.1 | 0.087 |
| 90–94 | 66.7 | 50 | 0.7 |
Results of univariate analysis between lumbar spinal stensis (LSS) or the other seven comorbid conditions and quality of life (QoL).
| LSS | Knee OA | Hip OA | Hypertension | Cerebrovascular disease | Respiratory disease | Cardiovascular disease | Diabetic mellitus | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| + | − | + | − | + | − | + | − | + | − | + | − | + | − | + | − | |
| PF | 68.8 | 80.71 | 71.1 | 81.81 | 75.0 | 78.5 | 75.7 | 79.14 | 60.2 | 78.16 | 76.7 | 77.9 | 75.0 | 78.2 | 74.2 | 78.0 |
| 48.2 | 50.94 | 49.1 | 51.01 | 48.7 | 50.45 | 50.9 | 50.4 | 44.6 | 50.76 | 52.6 | 50.6 | 51.2 | 50.5 | 49.7 | 50.6 | |
| RP | 50.8 | 70.71 | 53.6 | 72.71 | 67.2 | 66.4 | 61.7 | 68.26 | 51.6 | 66.0 | 25.0 | 65.97 | 51.6 | 67.52 | 59.7 | 66.0 |
| 45.2 | 48.81 | 45.8 | 49.11 | 47.5 | 48.1 | 47.8 | 48.2 | 45.7 | 48.1 | 38.4 | 48.17 | 45.7 | 48.45 | 46.7 | 48.1 | |
| BP | 55.9 | 71.11 | 61.1 | 71.31 | 64.0 | 68.2 | 67.2 | 68.8 | 64.6 | 68.2 | 55.3 | 68.2 | 65.2 | 68.5 | 63.2 | 68.47 |
| 45.0 | 50.11 | 47.3 | 49.91 | 46.7 | 49.17 | 49.3 | 49.3 | 48.6 | 49.3 | 45.6 | 49.3 | 48.8 | 49.4 | 47.8 | 49.4 | |
| GH | 51.9 | 64.51 | 55.8 | 64.12 | 54.5 | 62.12 | 59.3 | 63.32 | 48.1 | 62.13 | 48.3 | 61.97 | 51.9 | 62.91 | 56.7 | 62.16 |
| 46.7 | 51.71 | 48.5 | 51.41 | 46.8 | 50.92 | 50.0 | 51.26 | 45.7 | 50.95 | 45.4 | 50.8 | 47.2 | 51.21 | 48.4 | 50.96 | |
| VT | 62.9 | 71.11 | 66.5 | 71.11 | 67.7 | 69.5 | 69.3 | 69.6 | 65.4 | 69.6 | 55.6 | 69.6 | 69.1 | 69.6 | 66.1 | 69.7 |
| 49.7 | 52.91 | 51.3 | 52.95 | 51.1 | 52.3 | 52.4 | 52.3 | 50.5 | 52.4 | 46.8 | 52.4 | 52.5 | 52.4 | 51.1 | 52.4 | |
| SF | 81.8 | 86.91 | 84.7 | 86.4 | 84.2 | 85.9 | 84.4 | 86.87 | 83.6 | 86.0 | 91.7 | 85.9 | 84.5 | 86.1 | 84.1 | 86.0 |
| 49.8 | 51.3 | 51.0 | 51.07 | 49.7 | 51.0 | 50.7 | 51.3 | 50.4 | 51.1 | 54.4 | 51.1 | 51.0 | 51.1 | 50.5 | 51.1 | |
| RE | 57.9 | 74.71 | 62.2 | 75.31 | 71.0 | 71.2 | 65.0 | 73.54 | 66.7 | 70.5 | 22.2 | 70.66 | 59.3 | 71.84 | 62.7 | 70.8 |
| 46.0 | 49.36 | 47.1 | 49.3 | 48.0 | 48.7 | 47.6 | 49.16 | 47.8 | 48.6 | 37.1 | 48.67 | 46.5 | 48.86 | 46.6 | 48.7 | |
| MH | 69.7 | 75.41 | 72.5 | 74.76 | 72.3 | 74.3 | 74.3 | 74.5 | 74.3 | 74.4 | 74.0 | 74.4 | 71.7 | 74.77 | 72.0 | 74.5 |
| 48.4 | 51.11 | 49.9 | 50.17 | 49.4 | 50.6 | 50.6 | 50.6 | 51.2 | 50.6 | 50.1 | 50.6 | 49.4 | 50.77 | 49.6 | 50.7 | |
| PCS* | 45.2 | 48.11 | 45.4 | 48.41 | 47.8 | 47.5 | 47.7 | 47.5 | 43.2 | 47.67 | 38.0 | 47.67 | 46.3 | 47.47 | 46.3 | 47.6 |
| MCS* | 51.1 | 52.6 | 52.3 | 52.2 | 50.0 | 52.35 | 52.3 | 52.4 | 53.2 | 52.3 | 56.9 | 52.3 | 51.9 | 52.4 | 52.3 | 52.4 |
Upper: average of original score (0−100).
Lower: average of standardized score (average = 50, one-standard deviation = 10).
*PCS, MCS: only standardized score is available.
1 P < 0.0001, 2 P < 0.0005, 3 P < 0.001, 4 P < 0.005, 5 P < 0.01, 6 P < 0.05, and 7 P < 0.1.
PF: physical functioning; RP: role-physical; BP: bodily pain; GH: general health perception; VT: vitality; SF: social functioning; RE: role-emotional; MH: mental health; PCS: physical component summary; MCS: mental component summary.
Results of multiple logistic regression analysis between lumbar spinal stenosis (LSS), the other seven comorbid conditions, body mass index (BMI), or smoking and quality of life (QoL).
| BMI | Smoking exp. (pack·year) | LSS | Knee OA | Hip OA | Hypertension | Cerebrovascular disease | Respiratory disease | Cardiovascular disease | Diabetic mellitus | |
|---|---|---|---|---|---|---|---|---|---|---|
| PF | ||||||||||
| Odds ratio | 0.994 | 1.001 |
|
| 1.242 | 0.945 | 1.856 | 0.769 | 1.185 | 1.623 |
| 95% CI | 0.951, | 1.000 | 1.262, | 1.197, | 0.671, | 0.705, | 0.650, | 0.064, | 0.766, | 0.842, |
| 1.039 | 1.001 | 2.441 | 2.160 | 2.299 | 1.266 | 5.298 | 9.263 | 1.832 | 3.130 | |
| RP | ||||||||||
| Odds ratio | 0.991 | 1.000 |
|
| 1.009 | 1.158 | 1.343 | 1.242 · 107 | 1.369 | 0.943 |
| 95% CI | 0.950 | 1.000 | 1.284, | 1.287, | 0.549, | 0.875 | 0.459, | 0.000 | 0.890, | 0.487, |
| 1.034 | 1.001 | 2.492 | 2.291 | 1.853 | 1.534 | 3.928 | — | 2.104 | 1.828 | |
| BP | ||||||||||
| Odds ratio | 1.009 | 1.000 |
|
|
| 0.891 | 1.386 | 6.903 · 106 | 1.132 | 1.745 |
| 95% CI | 0.968, | 1.000 | 1.806, | 1.057, | 1.212, | 0.675, | 0.455, | 0.000 | 0.732, | 0.879, |
| 1.051 | 1.001 | 3.585 | 1.876 | 4.612 | 1.177 | 4.227 | — | 1.752 | 3.464 | |
| GH | ||||||||||
| Odds ratio | 0.986 | 1.000 |
|
| 1.462 | 1.219 | 1.548 | 3.074 |
| 1.256 |
| 95% CI | 0.954, | 1.000 | 1.466, | 1.056, | 0.886, | 0.977, | 0.664, | 0.599 | 1.200, | 0.772, |
| 1.018 | 1.000 | 2.507 | 1.678 | 2.413 | 1.522 | 3.610 | 15.77 | 2.507 | 2.043 | |
| VT | ||||||||||
| Odds ratio | 1.023 | 1.000 |
| 1.239 | 1.048 | 0.834 | 1.596 | 0.852 | 1.013 | 1.519 |
| 95% CI | 0.979, | 1.000, | 1.638, | 0.918, | 0.560, | 0.619, | 0.560, | 0.071, | 0.644, | 0.790, |
| 1.070 | 1.000 | 2.976 | 1.673 | 1.962 | 1.123 | 4.548 | 10.226 | 1.594 | 2.920 | |
| SF | ||||||||||
| Odds ratio | 0.989 | 1.000 |
| 1.003 | 1.420 | 1.248 | 1.144 | 1.823/107 | 0.987 | 0.798 |
| 95% CI | 0.947, | 1.000, | 1.109, | 0.743, | 0.772, | 0.936, | 0.379, | 0.000, | 0.632, | 0.395, |
| 1.033 | 1.001 | 2.158 | 1.353 | 2.610 | 1.665 | 3.303 | — | 1.540 | 1.611 | |
| RE | ||||||||||
| Odds ratio | 0.973 | 1.000 |
|
| 1.126 | 1.289 | 1.122 | 1.433 · 107 | 1.402 | 1.125 |
| 95% CI | 0.931, | 1.000 | 1.411, | 1.021, | 0.613, | 0.965, | 0.390, | 0.000 | 0.910, | 0.571 |
| 1.018 | 1.000 | 2.731 | 1.850 | 2.067 | 1.721 | 3.232 | — | 2.160 | 2.214 | |
| MH | ||||||||||
| Odds ratio |
| 1.000 |
| 0.992 | 1.205 | 0.993 | 0.614 | 0.817 | 1.269 | 0.907 |
| 95% CI | 0.923, | 0.999 | 1.199, | 0.787, | 0.746, | 0.795, | 0.266, | 0.191, | 0.891, | 0.557, |
| 0.986 | 1.000 | 2.027 | 1.251 | 1.946 | 1.240 | 1.418 | 3.500 | 1.807 | 1.478 | |
| PCS | ||||||||||
| Odds ratio | 1.006 | 1.000 |
|
| 1.308 | 1.014 | 1.089 | 1.009 · 107 |
| 0.833 |
| 95% CI | 0.963, | 1.000, | 1.190, | 1.413, | 0.704, | 0.761, | 0.386, | 0.000 | 1.090, | 0.423, |
| 1.050 | 1.001 | 2.341 | 2.550 | 2.431 | 1.351 | 3.072 | — | 2.667 | 1.641 | |
| MCS | ||||||||||
| Odds ratio |
| 1.000 | 1.160 | 0.870 | 1.201 | 1.059 | 0.590 | 1.388/107 | 0.896 | 1.388 |
| 95% CI | 0.909, | 0.999, | 0.825, | 0.643, | 0.652, | 0.794, | 0.185, | 0.000 | 0.569, | 0.720, |
| 0.993 | 1.000 | 1.631 | 1.176 | 2.211 | 1.414 | 1.884 | — | 1.410 | 2.674 | |
| No. of positive subjects for HR-QoL |
|
|
|
|
|
|
|
|
|
|
| No. of negative subjects for HR-QoL |
|
|
|
|
|
|
|
|
|
|
| Overall prevalence (%) |
|
|
|
|
|
|
|
|
PF: physical functioning; RP: role-physical; BP: bodily pain; GH: general health perception; VT: vitality; SF: social functioning; RE: role-emotional; MH: mental health; PCS: physical component summary; MCS: mental component summary.
No. of positive subjects for HR-QoL: number of positive influence on 10 aspects of SF-36.
No. of negative subjects for HR-QoL: number of negative influence on 10 aspects of SF-36.